Insights from Egyptian ticagrelor study in patients who presented with acute coronary syndrome (ETS in ACS)

BACKGROUND: Dual antiplatelet therapy with aspirin and a thienopyridine is used to prevent thrombotic complications of acute coronary syndrome (ACS) and percutaneous coronary interventions (PCI). Ticagrelor is an oral, reversible inhibitor of the adenosine diphosphate receptor P2Y12 with a faster on...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Hesham S., Kandil, Hossam, Farag, Nabil, Zaki, Amr, Mahrous, Hossam, Shaker, Mirna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213624/
https://www.ncbi.nlm.nih.gov/pubmed/35727384
http://dx.doi.org/10.1186/s43044-022-00290-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213624/
https://www.ncbi.nlm.nih.gov/pubmed/35727384
http://dx.doi.org/10.1186/s43044-022-00290-w

Ejemplares similares